$4.76 0.23 (+5.08%)
11/23/2009 3:50 PM

SenoRx, Inc. (SENO)

CAPS Rating: 5 out of 5

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

No one has written a Pitch for SENO stock yet. Tell us why you think SENO will outperform or underperform the S&P 500.

Featured Broker Partners